128 related articles for article (PubMed ID: 7637097)
1. The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer.
Leibovitch I; Baniel J; Foster RS; Donohue JP
J Urol; 1995 Sep; 154(3):935-9. PubMed ID: 7637097
[TBL] [Abstract][Full Text] [Related]
2. Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer?
Aki FT; Bilen CY; Tekin MI; Ozen H
Urology; 2000 Sep; 56(3):459-62. PubMed ID: 10962315
[TBL] [Abstract][Full Text] [Related]
3. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
4. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
5. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
7. Conservative surgical therapy for leydig cell tumor.
Carmignani L; Colombo R; Gadda F; Galasso G; Lania A; Palou J; Algaba F; Villavicencio H; Colpi GM; Decobelli O; Salvioni R; Pizzocaro G; Rigatti P; Rocco F
J Urol; 2007 Aug; 178(2):507-11; discussion 511. PubMed ID: 17561156
[TBL] [Abstract][Full Text] [Related]
8. Scrotal orchiectomy for a large testicular seminoma.
Lo KC; Wong C; Emond J; Aprikian AG
Can J Urol; 2001 Apr; 8(2):1234-6. PubMed ID: 11375787
[TBL] [Abstract][Full Text] [Related]
9. A review of the efficacy of surgical treatment for and pathological changes in patients with chronic scrotal pain.
Nariculam J; Minhas S; Adeniyi A; Ralph DJ; Freeman A
BJU Int; 2007 May; 99(5):1091-3. PubMed ID: 17244279
[TBL] [Abstract][Full Text] [Related]
10. Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.
Boyer MJ; Cox K; Tattersall MH; Findlay MP; Grygiel J; Rogers J
Urology; 1997 Oct; 50(4):588-92. PubMed ID: 9338737
[TBL] [Abstract][Full Text] [Related]
11. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
12. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
[TBL] [Abstract][Full Text] [Related]
13. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
14. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
[TBL] [Abstract][Full Text] [Related]
15. The role of salvage hemiscrotectomy in testicular cancer after scrotal contamination: a case report and literature review.
Khetpal R; Katz MD; Cox M; Arnaoutakis K
Clin Genitourin Cancer; 2014 Jun; 12(3):e103-5. PubMed ID: 24461625
[No Abstract] [Full Text] [Related]
16. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
17. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
[TBL] [Abstract][Full Text] [Related]
18. A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?
Capelouto CC; Clark PE; Ransil BJ; Loughlin KR
J Urol; 1995 Mar; 153(3 Pt 2):981-5. PubMed ID: 7853587
[TBL] [Abstract][Full Text] [Related]
19. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
Foster RS; Baniel J; Leibovitch I; Curran M; Bihrle R; Rowland R; Donohue JP
J Urol; 1996 Jun; 155(6):1943-5. PubMed ID: 8618293
[TBL] [Abstract][Full Text] [Related]
20. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS
J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
